Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/Topas Therapeutics

Topas Therapeutics

Series B
Hamburg, GermanyFounded 2006Oct 2020
Healthtech

Topas Therapeutics raised €22M in a Series B round in Oct 2020. The company is based in Hamburg, Germany. Investors in the round: BioMedPartners, Vesalius Biocapital Partners. Data as of Nov 2026.

← Topas Therapeutics
Amount raised
€22M
€22,000,000
Native amount
22,000,000 EUR
Stage
Series B
series b
Investors
2

Provenance & confidence

Low confidence
Amount

Reported in EUR — no conversion. €22M

High confidence
Source

biospace.com · unknown

Low confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

2 named
BioMedPartnersVesalius Biocapital Partners
Date
Oct 2020
Round type
series b
Amount (EUR)
€22M

Other rounds

same company

Related news